PL
PL · PL · PL-100162716
Naglazyme
ATC A16AB08
Last synced from URPL (Poland) on
Identification
ManufacturerBioMarin International Ltd.
CountryPL (PL)
ATC codeA16AB08
Dispensing—
ReimbursedNo
SourceURPL (Poland)
Last synced6/14/2026
Packs · 2
- gtin05909990614745
- gtin00368135020141
Annotations
No annotations yet.
Raw payload (JSON)
{
"form": "Koncentrat do sporządzania roztworu do infuzji",
"source": "urpl",
"strength": "1 mg/ml",
"packaging": "05909990614745 ¦ Rpz ¦ Skasowane ¦ EU/1/05/324/001 ¦ 33439\n1 fiol. 5 ml\nRpz ¦ EU/1/05/324/002 ¦ 104663\n6 fiol. 5 ml\n00368135020141 ¦ Rpz ¦ EU/1/05/324/001 ¦ 166365\n1 fiol. 5 ml",
"substance": "Galsufaze 1 mg",
"common_name": "Galsulfasum",
"pl_product_id": "100162716",
"pozwolenie_nr": null,
"auth_procedure": "CEN",
"authorisation_validity": null
}Related drugs
Other records sharing ATC code A16AB08.
- NONaglazymeBioMarin International Limited
- 🇨🇭NaglazymeDRAC AG
- DKNaglazymeBioMarin International Limited
- ISNaglazymeBioMarin International Limited
- FINaglazymeBiomarin International Limited
- CANAGLAZYMEBIOMARIN PHARMACEUTICAL INC.
- CZNAGLAZYMEBioMarin International Limited, Dublin
- 🇺🇸NAGLAZYMEBioMarin Pharmaceutical Inc.
Access this data programmatically
Query Naglazyme and 610,000+ other drug records through a single REST API — with a last_synced_at provenance stamp on every response. Free tier includes 100 requests/day.